Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy
Cell Biomaterials · 2026-08 · 100551
DOI: 10.1016/j.celbio.2026.100551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biomaterials, 2026-08. Verfasst von Zaigang Zhou und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- National Key Research and Development Program of China
- Wenzhou Medical University
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhou, Z., Li, C., Liu, J., Xiong, W., Ding, H., Wu, S., Wang, Z., Li, Z., Wang, L., & Shen, J. (2026). Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy. Cell Biomaterials, 100551. https://doi.org/10.1016/j.celbio.2026.100551
Vancouver
Zhou Z, Li C, Liu J, Xiong W, Ding H, Wu S, et al. Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy. Cell Biomaterials. 2026:100551. doi:10.1016/j.celbio.2026.100551
BibTeX
@article{Zhou2026,
author = {Zhou, Zaigang and Li, Cheng and Liu, Jiahao and Xiong, Wei and Ding, Huan and Wu, Sheng and Wang, Zhengxiang and Li, Zhipeng and Wang, Long and Shen, Jianliang},
title = {Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy},
journal = {Cell Biomaterials},
year = {2026},
pages = {100551},
doi = {10.1016/j.celbio.2026.100551}
}
EUVIMED